glp 1 and chronic kidney disease GLP1 Receptor Agonists vs SGLT2-I in Preventing CKD in T2DM: An Interview – AJKD Blog GLP-1 and the kidney: from

Bounous G, Baruchel S, Falutz J, Gold P (junio de 1993)

Five-year follow-up data presented at the AAOS 2026 meeting indicated that GLP-1 users had a significantly higher risk of osteoporosis than matched controls (4.1% to 3.2%)

Peptide Therapy for Testosterone (Pros) Stimulates the bodys natural testosterone production May help restore hormonal balance without shutting down testicular function Often considered safer for long-term use Can support other benefits (improved sleep, recovery, fat loss) depending on the peptide used Peptide Therapy for Testosterone (Cons) Results are slower and increases can take from 412 weeks compared to TRT, which is almost immediate Not FDA-approved Effects can be less dramatic for men with very low testosterone levels TRT for Testosterone (Pros) Provides almost immediate results, often noticeable within days to weeks Effective for men with significantly low testosterone levels Well-established treatment, widely prescribed and monitored TRT for Testosterone (Cons) Can suppress your body's natural testosterone production over time Long-term use may lead to testicular shrinkage and also infertility This treatment requires regular blood work and ongoing medical monitoring TRT may increase risk of blood clots, prostate issues, and cardiovascular strain in some men What are the possible side effects

It helps reduce dullness, dark spots, and pigmentation, while restoring your skins radiance and softness